INCY

Dhanak Dashyant

Known title: EVP & Chief Scientific OfficerCIK: 0001760682

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Incyte receives mixed analyst updates with price target changes. Incyte saw two recent analyst actions with differing views. Truist Securities raised its price target to $115 while maintaining a Hold rating. Conversely, HC Wainwright reiterated a Buy rating and kept its target at $152. These moves reflect a wide range of expectations among analysts for the stock's future performance.

this person other insiders at INCY

Transaction History

INCY▲ Buy$0
INCY▼ Sell$375K
INCY▲ Buy$242K
INCY▼ Sell$206K
INCY▲ Buy$0
INCY▼ Sell$44K
INCY▼ Sell$173K
INCY▲ Buy$0
INCY▲ Buy$0
INCY▼ Sell$35K
INCY▲ Buy$0
INCY▲ Buy$0
INCY▼ Sell$27K
INCY▼ Sell$30K

We use analytics to understand how market-wall is used. No personal data is sold.